Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines?
<p> <b>Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines?</b> </p> <p> <b>A.A. Olina</b> </p> <p> <b>D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St. Pet...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LCC «Medicine-Inform»
2020-06-01
|
| Series: | РМЖ. Мать и дитя |
| Online Access: | http://wchjournal.com/upload/iblock/0ff/0ffe0c16bd4d631fa7b1c537f49a6399.pdf |
| Summary: | <p>
<b>Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines?</b>
</p>
<p>
<b>A.A. Olina</b>
</p>
<p>
<b>D.O. Ott Research Institute of Obstetrics, Gynaecology and Reproduction, St. Petersburg, Russian Federation</b>
</p>
<p>
<i><b>Aim</b>: to analyze whether hyperprolactinemia contributes to missed miscarriage and to assess the efficacy of the treatment with plant-derived dopamine agonists.</i>
</p>
<p>
<i><b>Patients and Methods:</b> 375 women with anamnestic missed miscarriage before 14 weeks of pregnancy were enrolled. Women with the first and the only missed miscarriage (n=218) were included in group 1. Women with the first and subsequent pregnancies that resulted in intrauterine fetal death (n=157) were included in group 2. The levels of prolactin, thyroid-stimulating hormone (TSH), and thyroid peroxidase antibodies (TPO Abs) were measured. MRI with contrast was performed as needed. Cyclodynon<sup>®</sup> (1 tablet daily for 3 months) was prescribed for hyperprolactinemia.</i>
</p>
<p>
<i><b>Results</b>: elevated prolactin levels were revealed in 45 women (significant differences between group 1 and group 2 were demonstrated). All women with hyperprolactinemia underwent pituitary MRI with contrast. Pituitary microadenoma was identified in 16 w omen (group 1, n=5, 2.3%; group 2, n=11, 7.0%). In a total of 16 women, pituitary adenoma was identified for the first time. Gynecological examination has demonstrated that 20 women are infertile, i.e., 7 women in group 1 (3.2%) and 13 women in group 2 (8.3%). Elevated TSH was revealed in 23 women with missed miscarriage (6.1%), one in two woman (n=13) had hyperprolactinemia. Elevated TPO Abs were revealed in 59 women (15.7%), 17 out of 59 women (28.9%) had hyperprolactinemia, 17 out of 59 women (28.9%) had elevated THS, and 9 out of 59 women (15.3%) had hyperprolactinemia and elevated TSH.</i>
</p>
<p>
<i><b>Conclusions</b>: hyperprolactinemia was identified in every ten woman with anamnestic missed miscarriage. Significant differences between women with the only pregnancy loss and women with subsequent pregnancy loss were revealed. 35.6% of women with hyperprolactinemia were diagnosed with microadenoma. Treatment efficacy for both organic and functional hyperprolactinemia was 91.1%.</i>
</p>
<p>
<i><b>Keywords</b>: infertility, miscarriage, missed miscarriage, hyperprolactinemia, pituitary microadenoma, dopamine agonist.</i>
</p>
<p>
<i><b>For citation:</b> Olina A.A. Missed miscarriage and hyperprolactinemia. Is there a place for plant-derived medicines? Russian Journal of Woman and Child Health. 2020;3(2):64–69. DOI: 10.32364/2618-8430-2020-3-2-64-69.</i>
</p>
<i><br>
</i><br> |
|---|---|
| ISSN: | 2618-8430 2686-7184 |